Toujeo established similar glycemic control and hypoglycemic events vs Tresiba BRIGHT and INRANGE head-to-head studies support the Toujeo EDITION PIVOTAL STUDIES, which can be reviewed HERE *Baseline: 8.72% 0.83% for Toujeo, 8.57% 0.80% for Tresiba
The proportion of patients achieving NASH resolution in the absence of fibrosis progression was 40%, 36%, and 59% for the 0.1, 0.2, and 0.4 mg semaglutide arms, respectively, whereas the corresponding rate in the placebo arm was 17% ( Notably, based on the results from part 1 of the ESSENCE trial, on 15 August 2025, the FDA approved semaglutide 2.4 mg for the treatment of adults with MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis)
This dual action provides enhanced appetite suppression and metabolic effects, leading to greater weight loss compared to Semaglutides single-receptor action
Bottom line: Taking L-carnitine with vitamin C is a safe and science-backed way to support fat metabolism and energy production
It can lower the risk of cardiovascular events such as heart attacks, strokes, or death in patients with type 2 diabetes and existing heart or blood vessel disease
Knowing that there are a few studies about the genomic data of the tyrosinase gene, there are only a handful of studies on the mutations in albino amphibians
